BLyS-Mediated Modulation of Naive B Cell Subsets Impacts HIV Env-Induced Antibody Responses
Open Access
- 15 June 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 188 (12) , 6018-6026
Abstract
Neutralizing Abs provide the protective effect of the majority of existing human vaccines. For a prophylactic vaccine against HIV-1, broadly neutralizing Abs targeting conserved epitopes of the viral envelope glycoproteins (Env) are likely required, because the pool of circulating HIV-1 variants is extremely diverse. The failure to efficiently induce broadly neutralizing Abs by vaccination may be due to the use of suboptimal immunogens or immunization regimens, or it may indicate that B cells specific for broadly neutralizing Env determinants are selected against during peripheral checkpoints, either before or after Ag encounter. To investigate whether perturbation of B cell subsets prior to immunization with recombinant Env protein affects the vaccine-induced Ab response in mice, we used B lymphocyte stimulator (BLyS), a cytokine that regulates survival and selection of peripheral B cells. We show that the transient BLyS treatment used in this study substantially affected naive B cell populations; in particular, it resulted in more B cells surviving counter-selection at the transitional stages. We also observed more mature naive B cells, especially marginal zone B cells, in BLyS-treated mice. Intriguingly, provision of excess BLyS prior to immunization led to a consistent improvement in the frequency and potency of HIV-1 Env vaccine-induced neutralizing Ab responses, without increasing the number of Env-specific Ab-secreting cells or the Ab-binding titers measured after boosting. The results presented in this article suggest that an increased understanding of BLyS-regulated processes may help the design of vaccine regimens aimed at eliciting improved neutralizing Ab responses against HIV-1.Keywords
This publication has 50 references indexed in Scilit:
- Biochemically Defined HIV-1 Envelope Glycoprotein Variant Immunogens Display Differential Binding and Neutralizing Specificities to the CD4-binding SiteJournal of Biological Chemistry, 2012
- Soluble multi-trimeric TNF superfamily ligand adjuvants enhance immune responses to a HIV-1 Gag DNA vaccineVaccine, 2012
- Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutatedJournal of Experimental Medicine, 2011
- Broad neutralization coverage of HIV by multiple highly potent antibodiesNature, 2011
- Aromatic residues at the edge of the antibody combining site facilitate viral glycoprotein recognition through membrane interactionsProceedings of the National Academy of Sciences, 2010
- BAFF overexpression promotes anti-dsDNA B-cell maturation and antibody secretionCellular Immunology, 2010
- Autoreactivity in an HIV-1 broadly reactive neutralizing antibody variable region heavy chain induces immunologic toleranceProceedings of the National Academy of Sciences, 2009
- Tonic B cell antigen receptor signals supply an NF-κB substrate for prosurvival BLyS signalingNature Immunology, 2008
- Repertoire-based selection into the marginal zone compartment during B cell developmentJournal of Experimental Medicine, 2008
- Efficient protein boosting after plasmid DNA or recombinant adenovirus immunization with HIV-1 vaccine constructsVaccine, 2007